Receptor-type Tyrosine-protein Phosphatase-like N (PTPRN)

<strong>Receptor-type Tyrosine-protein Phosphatase-like N (PTPRN)</strong>_x000D_ <strong>Catalog number:</strong> B2012408_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 46 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> R-PTP-N, Islet cell antigen 512, ICA 512, Islet cell autoantigen 3, PTP IA-2, PTPRN_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kang T, Ye J, Qin P, Li H, Yao Z, Liu Y, Ling Y, Zhang Y, Yu T, Cao H, Li Y, Wang J, Fang F. Knockdown of Ptprn-2 delays the onset of puberty in female rats Theriogenology. 2021 Dec;176:137-148._x000D_ 2: Song X, Jiao X, Yan H, Yu L, Jiang L, Zhang M, Chen L, Ju M, Wang L, Wei Q, Zhao L, Wei M. Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity Front Cell Dev Biol. 2021 Jun 2;9:622018._x000D_ 3: Wang D, Tang F, Liu X, Fan Y, Zheng Y, Zhuang H, Chen B, Zhuo J, Wang B. Expression and Tumor-Promoting Effect of Tyrosine Phosphatase Receptor Type N (PTPRN) in Human Glioma Front Oncol. 2021 Sep 7;11:676287._x000D_ 4: Li P, Chen F, Yao C, Zhu K, Zhang B, Zheng Z. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma Brain Sci. 2022 Jun 10;12(6):763._x000D_ 5: Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N. Current Challenges and Opportunities in Treating Glioblastoma Pharmacol Rev. 2018 Jul;70(3):412-445._x000D_ 6: Zhu X, Pan S, Li R, Chen Z, Xie X, Han D, Lv S, Huang Y. Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma Front Oncol. 2021 Dec 15;11:667884._x000D_ 7: Garranzo-Asensio M, Solís-Fernández G, Montero-Calle A, García-Martínez JM, Fiuza MC, Pallares P, Palacios-Garcia N, García-Jiménez C, Guzman-Aranguez A, Barderas R. Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target Diabetes. 2022 Mar 1;71(3):497-510._x000D_ 8: Luo X, Tu T, Zhong Y, Xu S, Chen X, Chen L, Yang F. ceRNA Network Analysis Shows That lncRNA CRNDE Promotes Progression of Glioblastoma Through Sponge mir-9-5p Front Genet. 2021 Mar 9;12:617350._x000D_ 9: Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children JAMA. 2013 Jun 19;309(23):2473-9._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29742497">10: Zhangyuan G, Yin Y, Zhang W, Yu W, Jin K, Wang F, Huang R, Shen H, Wang X, Sun B. Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma Cell Physiol Biochem. 2018;46(6):2335-2346. </a>_x000D_ _x000D_ <strong>Products Related to Receptor-type Tyrosine-protein Phosphatase-like N (PTPRN) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>